Literature DB >> 34138411

Methamphetamine Exposure During Development Causes Lasting Changes to Mesolimbic Dopamine Signaling in Mice.

Daniel J Torres1,2, Jordan T Yorgason3, Marilou A Andres4, Frederick P Bellinger5.   

Abstract

Methamphetamine (MA) abuse remains a public health issue. Prenatal MA exposure (PME) poses a significant health problem, as we know very little about the drug's long-term physiological impact on the developing human brain. We investigated the long-term consequences of early MA exposure using a mouse model that targets the brain growth spurt, which occurs during human third-trimester. Adult mice previously subjected to acute MA during post-natal days 4-9 exhibited hyperactivity during the Open-Field Test, while exhibiting no motor coordination changes during the Rotarod Test. Neonatal MA exposure reduced basal dopamine (DA) uptake rates in adult nucleus accumbens slices compared with saline-injected controls. Although slices from neonatal MA-exposed mice showed no change in evoked DA signals in the presence of MA, they exhibited potentiated non-evoked DA release through DA efflux in response to MA. These data suggest that developmental MA exposure alters brain development to produce long-lasting physiological changes to the adult mesolimbic DA system, as well as altering responses to acute MA exposure in adulthood. This study provides new insights into an important, under-investigated area in drugs of abuse research.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Development; Dopamine; Fast-scan cyclic voltammetry; Methamphetamine; Prenatal methamphetamine exposure

Mesh:

Substances:

Year:  2021        PMID: 34138411      PMCID: PMC8678368          DOI: 10.1007/s10571-021-01120-4

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   4.231


  38 in total

1.  Effects of prenatal methamphetamine exposure on behavioral and cognitive findings at 7.5 years of age.

Authors:  Sabrina D Diaz; Lynne M Smith; Linda L LaGasse; Chris Derauf; Elana Newman; Rizwan Shah; Amelia Arria; Marilyn A Huestis; Sheri Della Grotta; Lynne M Dansereau; Charles Neal; Barry M Lester
Journal:  J Pediatr       Date:  2014-03-12       Impact factor: 4.406

2.  Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; D Franceschi; M Sedler; S J Gatley; E Miller; R Hitzemann; Y S Ding; J Logan
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

3.  Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry.

Authors:  Q Wu; M E Reith; R M Wightman; K T Kawagoe; P A Garris
Journal:  J Neurosci Methods       Date:  2001-12-15       Impact factor: 2.390

4.  Neonatal +-methamphetamine exposure in rats alters adult locomotor responses to dopamine D1 and D2 agonists and to a glutamate NMDA receptor antagonist, but not to serotonin agonists.

Authors:  Devon L Graham; Robyn M Amos-Kroohs; Amanda A Braun; Curtis E Grace; Tori L Schaefer; Matthew R Skelton; Michael T Williams; Charles V Vorhees
Journal:  Int J Neuropsychopharmacol       Date:  2012-03-06       Impact factor: 5.176

5.  Alterations in adult behavioral responses to cocaine and dopamine transporters following juvenile exposure to methamphetamine.

Authors:  Lisa McFadden; Bryan K Yamamoto; Leslie Matuszewich
Journal:  Behav Brain Res       Date:  2010-09-09       Impact factor: 3.332

6.  Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder.

Authors:  M Mereu; G Contarini; E F Buonaguro; G Latte; F Managò; F Iasevoli; A de Bartolomeis; F Papaleo
Journal:  Neuropharmacology       Date:  2017-04-26       Impact factor: 5.250

7.  Melatonin attenuates methamphetamine-induced reduction of tyrosine hydroxylase, synaptophysin and growth-associated protein-43 levels in the neonatal rat brain.

Authors:  Sukit Kaewsuk; Kwankanit Sae-ung; Pansiri Phansuwan-Pujito; Piyarat Govitrapong
Journal:  Neurochem Int       Date:  2009-05-04       Impact factor: 3.921

8.  Social isolation rearing increases dopamine uptake and psychostimulant potency in the striatum.

Authors:  Jordan T Yorgason; Erin S Calipari; Mark J Ferris; Anushree N Karkhanis; Steven C Fordahl; Jeffrey L Weiner; Sara R Jones
Journal:  Neuropharmacology       Date:  2015-10-23       Impact factor: 5.250

Review 9.  A comparison of the different animal models of fetal alcohol spectrum disorders and their use in studying complex behaviors.

Authors:  Anna R Patten; Christine J Fontaine; Brian R Christie
Journal:  Front Pediatr       Date:  2014-09-03       Impact factor: 3.418

Review 10.  Methamphetamine and the hypothalamic-pituitary-adrenal axis.

Authors:  Damian G Zuloaga; Jason S Jacobskind; Jason S Jacosbskind; Jacob Raber
Journal:  Front Neurosci       Date:  2015-05-27       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.